Operating Income (Loss) of IMMUCELL CORP /DE/ from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IMMUCELL CORP /DE/ quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Operating Income (Loss) for the quarter ending 30 Sep 2025 was $20,075.
  • IMMUCELL CORP /DE/ Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $2,328,655.
  • IMMUCELL CORP /DE/ annual Operating Income (Loss) for 2024 was $1,640,159, a 71% increase from 2023.
  • IMMUCELL CORP /DE/ annual Operating Income (Loss) for 2023 was $5,748,078, a 150% decline from 2022.
  • IMMUCELL CORP /DE/ annual Operating Income (Loss) for 2022 was $2,298,943, a 993% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

IMMUCELL CORP /DE/ Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,328,655 $20,075 +$594,969 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $1,733,686 $569,562 +$1,956,169 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $222,483 $1,117,624 +$1,417,676 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,640,159 $621,394 +$1,624,892 01 Oct 2024 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $3,265,051 $574,894 +$609,152 +51% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $3,874,203 $1,386,607 -$82,112 -6.3% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $3,792,091 $300,052 +$1,955,987 +87% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $5,748,078 $1,003,498 +$630,257 +39% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $6,378,335 $1,184,046 -$567,256 -92% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $5,811,079 $1,304,495 -$685,488 -111% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $5,125,591 $2,256,039 -$2,826,648 -495% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $2,298,943 $1,633,755 -$1,779,167 -1224% 01 Oct 2022 31 Dec 2022 10-Q 13 Nov 2024 2024 Q3
Q3 2022 $519,776 $616,790 -$887,880 -328% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $368,104 $619,007 -$834,515 -387% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $1,202,619 $570,609 +$945,234 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $257,385 $145,412 +$779,775 01 Oct 2021 31 Dec 2021 10-Q 13 Nov 2023 2023 Q3
Q3 2021 $522,390 $271,090 +$522,688 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2021 $1,045,078 $215,508 +$906,777 01 Apr 2021 30 Jun 2021 10-Q/A 21 Nov 2022 2022 Q2
Q1 2021 $1,951,855 $374,625 -$571,502 -290% 01 Jan 2021 31 Mar 2021 10-Q/A 21 Nov 2022 2022 Q1
Q4 2020 $1,380,353 $634,363 -$391,899 -162% 01 Oct 2020 31 Dec 2020 10-Q 21 Nov 2022 2022 Q3
Q3 2020 $988,454 $251,598 +$178,218 +41% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $1,166,672 $691,269 -$144,337 -26% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $1,022,335 $196,877 -$68,427 -26% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $953,908 $242,464 +$683,402 +74% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $1,637,310 $429,816 -$280,676 -188% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $1,356,634 $546,932 -$353,523 -183% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q2
Q1 2019 $1,003,111 $265,304 +$443,459 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $1,446,570 $925,866 -$512,530 -124% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
Q3 2018 $934,040 $149,140 +$333,271 +69% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $1,267,311 $193,409 +$71,898 +27% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $1,339,209 $178,155 -$1,096,364 -119% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q4 2017 $242,845 $413,336 -$532,645 -446% 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
Q3 2017 $289,800 $482,411 -$532,878 -1056% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $822,678 $265,307 -$286,772 -1336% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2
Q1 2017 $1,109,450 $918,209 +$219,245 +31% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q4 2016 $890,205 $119,309 -$342,128 -74% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2017 2016 FY
Q3 2016 $1,232,333 $50,467 -$576,383 -92% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $1,808,716 $21,465 -$192,518 -90% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $2,001,234 $698,964 -$121,088 -15% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $2,122,322 $461,437 +$262,581 +132% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 $1,859,741 $626,850 +$585,997 +1434% 01 Jul 2015 30 Sep 2015 10-K 30 Mar 2017 2016 FY
Q2 2015 $1,273,744 $213,983 +$672,650 01 Apr 2015 30 Jun 2015 10-K 30 Mar 2017 2016 FY
Q1 2015 $601,094 $820,052 +$807,491 +6429% 01 Jan 2015 31 Mar 2015 10-K 30 Mar 2017 2016 FY
Q4 2014 $206,397 $198,856 +$408,831 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 $615,228 $40,853 +$200,820 01 Jul 2014 30 Sep 2014 10-K 25 Mar 2016 2015 FY
Q2 2014 $816,048 $458,667 -$482,389 -2034% 01 Apr 2014 30 Jun 2014 10-K 25 Mar 2016 2015 FY
Q1 2014 $333,659 $12,561 -$314,105 -96% 01 Jan 2014 31 Mar 2014 10-K 25 Mar 2016 2015 FY
Q4 2013 $19,554 $209,975 -$222,472 -1780% 01 Oct 2013 31 Dec 2013 10-K 25 Mar 2016 2015 FY
Q3 2013 $202,918 $159,967 -$73,841 -86% 01 Jul 2013 30 Sep 2013 10-K 25 Mar 2016 2015 FY
Q2 2013 $276,759 $23,722 -$13,675 -37% 01 Apr 2013 30 Jun 2013 10-K 25 Mar 2016 2015 FY
Q1 2013 $290,434 $326,666 +$45,433 +16% 01 Jan 2013 31 Mar 2013 10-K 25 Mar 2016 2015 FY
Q4 2012 $245,001 $12,497 +$3,115 +33% 01 Oct 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
Q3 2012 $241,886 $86,126 +$106,264 +55% 01 Jul 2012 30 Sep 2012 10-K 26 Mar 2015 2014 FY
Q2 2012 $135,622 $37,397 +$470,257 01 Apr 2012 30 Jun 2012 10-K 26 Mar 2015 2014 FY
Q1 2012 $334,635 $281,233 +$298,091 01 Jan 2012 31 Mar 2012 10-K 26 Mar 2015 2014 FY
Q4 2011 $632,726 $9,382 01 Oct 2011 31 Dec 2011 10-K 26 Mar 2014 2013 FY
Q3 2011 $192,390 +$155,152 +45% 01 Jul 2011 30 Sep 2011 10-K 26 Mar 2014 2013 FY
Q2 2011 $432,860 -$480,490 -1009% 01 Apr 2011 30 Jun 2011 10-K 26 Mar 2014 2013 FY
Q1 2011 $16,858 01 Jan 2011 31 Mar 2011 10-K 26 Mar 2014 2013 FY
Q3 2010 $347,542 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q3
Q2 2010 $47,630 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2

IMMUCELL CORP /DE/ Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,640,159 +$4,107,919 +71% 01 Jan 2024 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
2023 $5,748,078 -$3,449,135 -150% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $2,298,943 -$2,556,328 -993% 01 Jan 2022 31 Dec 2022 10-Q 13 Nov 2024 2024 Q3
2021 $257,385 +$1,637,738 01 Jan 2021 31 Dec 2021 10-Q 13 Nov 2023 2023 Q3
2020 $1,380,353 -$426,445 -45% 01 Jan 2020 31 Dec 2020 10-Q 21 Nov 2022 2022 Q3
2019 $953,908 +$492,662 +34% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $1,446,570 -$1,203,725 -496% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $242,845 -$1,133,049 -127% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
2016 $890,204 -$1,232,118 -58% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018 2017 FY
2015 $2,122,322 +$2,328,720 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $206,398 -$186,846 -956% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $19,552 -$264,553 -108% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2016 2015 FY
2012 $245,001 +$877,727 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
2011 $632,726 +$57,555 +8.3% 01 Jan 2011 31 Dec 2011 10-K 26 Mar 2014 2013 FY
2010 $690,281 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.